Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 109251-109300 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04322136
AMPLE-3: IPC Plus Talc vs VATS in Management of Malignant Pleural Effusion
NARecruiting
160 participants
Started: May 29, 2018 · Completed: Dec 31, 2025
3 conditions24 sponsors1 location
NCT03415828
Ethanol Gel Versus Steroid in Refractory Lumbar Discogenic Pain
NARecruiting
230 participants
Started: May 29, 2018 · Completed: May 29, 2027
1 condition2 sponsors5 locations
NCT03388190
METIMMOX: Colorectal Cancer METastasis - Shaping Anti-tumor IMMunity by OXaliplatin
PHASE2Active, not recruiting
80 participants
Started: May 29, 2018 · Completed: Jun 30, 2025
1 condition5 sponsors5 locations
NCT03484494
Low Field Magnetic Stimulation: Imaging Biomarkers in Geriatric Bipolar Depression
NAActive, not recruiting
40 participants
Started: May 29, 2018 · Completed: May 21, 2025
4 conditions1 sponsor1 location
NCT04025541
Analysis of Circulating Tumor Markers in Blood
NARecruiting
992 participants
Started: May 29, 2018 · Completed: May 29, 2029
6 conditions1 sponsor2 locations
NCT04033952
Strategy Training on Improving Executive Functions in Persons Following Acquired Brain Injury
NAActive, not recruiting
180 participants
Started: May 29, 2018 · Completed: Sep 30, 2024
3 conditions1 sponsor3 locations
NCT03514368
Monitoring of Immunological Mechanisms and Biomarkers Underlying Efficacy and Toxicity of Cancer Immunotherapy
NARecruiting
570 participants
Started: May 28, 2018 · Completed: Nov 30, 2029
1 condition1 sponsor3 locations
NCT03410615
Cisplatin + Radiotherapy vs Durvalumab + Radiotherapy Followed by Durvalumab vs Durvalumab + Radiotherapy Followed by Tremelimumab + Durvalumab in Intermediate-Risk HPV-Positive Oropharyngeal SCC
PHASE2Active, not recruiting
129 participants
Started: May 28, 2018 · Completed: Jul 31, 2026
1 condition2 sponsors26 locations
NCT03685045
ETHOS ENGAGE: Enhancing Treatment of Hepatitis C in Opioid Substitution Settings
NARecruiting
6,000 participants
Started: May 28, 2018 · Completed: Jan 30, 2025
1 condition2 sponsors29 locations
NCT02969083
Feasibility of Neo-adjuvant Versus Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma
PHASE2Recruiting
200 participants
Started: May 28, 2018 · Completed: Dec 31, 2025
1 condition2 sponsors29 locations
NCT03523858
A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis
PHASE3Active, not recruiting
927 participants
Started: May 28, 2018 · Completed: Dec 4, 2026
1 condition1 sponsor125 locations
NCT03313206
Neoadjuvant Treatment Associated With Maintenance Therapy by Anti-PD1 Immunotherapy in Patients With Resectable Head and Neck Mucosal Melanoma
PHASE2Recruiting
60 participants
Started: May 28, 2018 · Completed: May 31, 2028
1 condition1 sponsor1 location
NCT03569735
Nanshan Elderly Cohort Study
N/ARecruiting
20,000 participants
Started: May 26, 2018 · Completed: Dec 30, 2028
10 conditions2 sponsors2 locations
NCT03660124
Deep Brain Stimulation (DBS) for the Treatment of Refractory Alcohol Use Disorder (AUD): Pilot Trial
NAActive, not recruiting
10 participants
Started: May 25, 2018 · Completed: Dec 25, 2024
1 condition1 sponsor1 location
NCT03289299
Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant
PHASE2Active, not recruiting
87 participants
Started: May 25, 2018 · Completed: Nov 15, 2031
1 condition5 sponsors10 locations
NCT03537690
FID-007 in Treating Participants With Advanced Solid Tumors
PHASE1Active, not recruiting
50 participants
Started: May 25, 2018 · Completed: May 25, 2027
2 conditions2 sponsors3 locations
NCT03414866
Thoraflex Hybrid Post-Market Study
N/AActive, not recruiting
182 participants
Started: May 25, 2018 · Completed: Jul 31, 2026
5 conditions1 sponsor7 locations
NCT04149613
Predictive and Prognostic Value of Inflammatory Markers and microRNA in Stage IV Colorectal Cancer
N/AEnrolling by invitation
100 participants
Started: May 25, 2018 · Completed: Jul 15, 2026
1 condition1 sponsor1 location
NCT03919877
Precision Diets for Diabetes Prevention
NAActive, not recruiting
100 participants
Started: May 24, 2018 · Completed: Dec 31, 2025
3 conditions2 sponsors1 location
NCT03645239
Post-operative Emesis and Pain Outcomes After Cesarean Delivery
N/AActive, not recruiting
595 participants
Started: May 24, 2018 · Completed: Dec 31, 2026
4 conditions1 sponsor1 location
NCT03687411
An Ultrasound Guided Automated Spinal Landmark Identification System
NARecruiting
200 participants
Started: May 24, 2018 · Completed: Dec 31, 2027
2 conditions1 sponsor1 location
NCT03608943
Hydrocortisone Vs Prednisolone in AI (HYPER-AID)
N/ARecruiting
100 participants
Started: May 24, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06209398
Immunogenicity of the Inactivated EV71 Vaccine Combined With Hepatitis B and Group A Meningococcal Vaccine
PHASE4Active, not recruiting
510 participants
Started: May 24, 2018 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT03709914
PK Study of Single-Dose ZTI-01 in Children (<12 Years of Age)
PHASE1Recruiting
21 participants
Started: May 24, 2018 · Completed: Jan 10, 2026
1 condition1 sponsor5 locations
NCT03561961
Prostate Radiotherapy Comparing Moderate and Extreme Hypo-fractionation (PRIME Trial)
NAActive, not recruiting
526 participants
Started: May 24, 2018 · Completed: Mar 31, 2035
1 condition2 sponsors1 location
NCT03501381
High Dose IL 2 and Entinostat in RCC
PHASE2Active, not recruiting
46 participants
Started: May 24, 2018 · Completed: Apr 30, 2024
1 condition4 sponsors5 locations
NCT02914405
Phase I Study of 131-I mIBG Followed by Nivolumab & Dinutuximab Beta Antibodies in Children With Relapsed/Refractory Neuroblastoma
PHASE1Active, not recruiting
44 participants
Started: May 24, 2018 · Completed: Nov 30, 2025
1 condition7 sponsors3 locations
NCT03396172
FreeDom: Innovative Strategy for the Management of COPD Exacerbations
NARecruiting
100 participants
Started: May 24, 2018 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT03533582
Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery
PHASE3Active, not recruiting
537 participants
Started: May 24, 2018 · Completed: Dec 31, 2026
5 conditions2 sponsors205 locations
NCT03645044
Towards a Functional Cure for HBV - The COMMIT Cohort Study
N/AActive, not recruiting
102 participants
Started: May 24, 2018 · Completed: Jul 31, 2025
2 conditions8 sponsors3 locations
NCT04283006
A Study of CD20/CD22 Targeted CAR T-cell Therapy for Relapsed or Refractory Lymphoid Malignancies
EARLY_PHASE1Recruiting
100 participants
Started: May 23, 2018 · Completed: May 23, 2028
2 conditions2 sponsors1 location
NCT03429036
Biospecimen Procurement for Head and Neck Disorders
N/ARecruiting
1,000 participants
Started: May 23, 2018 · Completed: Dec 3, 2026
5 conditions1 sponsor9 locations
NCT03566355
Curative Proton Beam Therapy for Patients With Lung Metastasis of Colorectal Cancer
NARecruiting
36 participants
Started: May 23, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05624372
Speech Perception in Noise in Children With ADHD
N/ARecruiting
100 participants
Started: May 22, 2018 · Completed: Mar 30, 2025
1 condition2 sponsors1 location
NCT03568266
Pharmacogenomics of Asparaginase Induced Hepatotoxicity
N/ARecruiting
500 participants
Started: May 22, 2018 · Completed: Dec 31, 2026
1 condition2 sponsors1 location
NCT06349226
Identification of Biomarkers and Molecular Targets Involved on Intervertebral Disc Degeneration and Discogenic Pain
N/ARecruiting
160 participants
Started: May 22, 2018 · Completed: May 21, 2025
3 conditions1 sponsor1 location
NCT03510104
Pharmacokinetic and Safety Study of MRX-2843 in Adults with Relapsed/Refractory Advanced And/or Metastatic Solid Tumors
PHASE1Active, not recruiting
42 participants
Started: May 22, 2018 · Completed: Apr 30, 2025
6 conditions1 sponsor2 locations
NCT02706652
Prospective Screening for Patient-Specific Genotypes and Phenotypes That Influence Drug Dosing and Trial Selection in Cancer Patients
N/AEnrolling by invitation
900 participants
Started: May 22, 2018 · Completed: Dec 1, 2026
1 condition1 sponsor1 location
NCT04539496
A Phase I/II Study of XZP-3287 in Metastasis Solid Tumors
PHASE1/PHASE2Active, not recruiting
402 participants
Started: May 22, 2018 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT03718910
DDX3X Syndrome -The Seaver Autism Center for Research and Treatment is Characterizing DDX3X-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures.
N/ARecruiting
10 participants
Started: May 22, 2018 · Completed: May 31, 2026
3 conditions1 sponsor1 location
NCT03452579
Nivolumab Plus Standard Dose Bevacizumab Versus Nivolumab Plus Low Dose Bevacizumab in GBM
PHASE2Active, not recruiting
90 participants
Started: May 21, 2018 · Completed: Jun 30, 2025
1 condition1 sponsor2 locations
NCT03583866
Adiposity and Endothelin Receptor Function
EARLY_PHASE1Active, not recruiting
25 participants
Started: May 21, 2018 · Completed: Jan 31, 2026
1 condition2 sponsors1 location
NCT03633162
Maternal Grandmothers in the Born in Guangzhou Cohort Study
N/ARecruiting
5,000 participants
Started: May 21, 2018 · Completed: Dec 31, 2038
5 conditions3 sponsors1 location
NCT03510442
Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, and Related Conditions
N/ARecruiting
2,000 participants
Started: May 21, 2018 · Completed: Jan 1, 2050
4 conditions1 sponsor1 location
NCT03577665
Curative Proton Beam Therapy for Patients With Liver Metastasis of Colorectal Cancer
NARecruiting
30 participants
Started: May 21, 2018 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT03417544
Atezolizumab + Pertuzumab + Trastuzumab In CNS Mets In BC
PHASE2Active, not recruiting
19 participants
Started: May 21, 2018 · Completed: Dec 31, 2025
2 conditions2 sponsors2 locations
NCT03556488
Ultrasonographic Air Bronchogram in Pediatric CAP
N/ARecruiting
30 participants
Started: May 21, 2018 · Completed: Apr 30, 2024
2 conditions1 sponsor2 locations
NCT03564340
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
PHASE1/PHASE2Recruiting
890 participants
Started: May 21, 2018 · Completed: Jan 31, 2027
6 conditions1 sponsor52 locations
NCT03573791
Biomarkers for Predicting Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal Cancer
N/ARecruiting
152 participants
Started: May 21, 2018 · Completed: May 21, 2027
7 conditions1 sponsor2 locations
NCT03669315
Modulating Inhibitory Control Networks in Gambling Disorder With Theta Burst Stimulation
PHASE3Recruiting
40 participants
Started: May 20, 2018 · Completed: Dec 1, 2019
1 condition1 sponsor1 location